- Home
- IXHL vs TOVX Comparison
IXHL vs TOVX Comparison
Compare IXHL & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- TOVX
- Stock Information
- Founded
- IXHL 2001
- TOVX 2001
- Country
- IXHL Australia
- TOVX United States
- Employees
- IXHL N/A
- TOVX N/A
- Industry
- IXHL
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- IXHL
- TOVX Health Care
- Exchange
- IXHL Nasdaq
- TOVX Nasdaq
- Market Cap
- IXHL 35.6M
- TOVX 4.5M
- IPO Year
- IXHL N/A
- TOVX 2006
- Fundamental
- Price
- IXHL $0.59
- TOVX $0.42
- Analyst Decision
- IXHL
- TOVX Hold
- Analyst Count
- IXHL 0
- TOVX 1
- Target Price
- IXHL N/A
- TOVX N/A
- AVG Volume (30 Days)
- IXHL 139.1M
- TOVX 1.2M
- Earning Date
- IXHL 09-29-2025
- TOVX 08-11-2025
- Dividend Yield
- IXHL N/A
- TOVX N/A
- EPS Growth
- IXHL N/A
- TOVX N/A
- EPS
- IXHL N/A
- TOVX N/A
- Revenue
- IXHL $98,000.00
- TOVX N/A
- Revenue This Year
- IXHL $2,538.49
- TOVX N/A
- Revenue Next Year
- IXHL $249.95
- TOVX N/A
- P/E Ratio
- IXHL N/A
- TOVX N/A
- Revenue Growth
- IXHL N/A
- TOVX N/A
- 52 Week Low
- IXHL $0.08
- TOVX $0.37
- 52 Week High
- IXHL $3.12
- TOVX $7.15
- Technical
- Relative Strength Index (RSI)
- IXHL 54.83
- TOVX 44.90
- Support Level
- IXHL $0.38
- TOVX $0.45
- Resistance Level
- IXHL $0.42
- TOVX $0.47
- Average True Range (ATR)
- IXHL 0.06
- TOVX 0.04
- MACD
- IXHL -0.00
- TOVX 0.00
- Stochastic Oscillator
- IXHL 88.35
- TOVX 31.76
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.